Viewing Option
China blood plasma products market is steadily growing from 2012 to more than double in 2017. It is anticipated that blood plasma products market in China will grow at a CAGR of 12.45 percent during the forecasting perio....
The global CAR-T Cell therapy market is anticipated to grow over 20 percent CAGR during the forecasting period and likely to touch nearly US$ 8 Billion landmarks in 2028. The year 2017 was the milestone year for the CAR-....
MNG Tracker anticipated that numbers of clinical trials and regulatory approvals for cell and gene therapies are expected to rise over the years to come. The US FDA anticipates that by 2025 it will approve 10 to 20 cell ....